Cargando…

Cellular reprogramming to model and study epigenetic alterations in cancer

Although genetic mutations are required for cancer development, reversible non-genetic alterations also play a pivotal role in cancer progression. Failure of well-orchestrated gene regulation by chromatin states and master transcription factors can be one such non-genetic etiology for cancer develop...

Descripción completa

Detalles Bibliográficos
Autor principal: Kim, Jungsun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768185/
https://www.ncbi.nlm.nih.gov/pubmed/33202305
http://dx.doi.org/10.1016/j.scr.2020.102062
_version_ 1783629108355268608
author Kim, Jungsun
author_facet Kim, Jungsun
author_sort Kim, Jungsun
collection PubMed
description Although genetic mutations are required for cancer development, reversible non-genetic alterations also play a pivotal role in cancer progression. Failure of well-orchestrated gene regulation by chromatin states and master transcription factors can be one such non-genetic etiology for cancer development. Master transcription factor-mediated cellular reprogramming of human cancer cells allows us to model cancer progression. Here I cover the history and recent advances in reprogramming cancer cells, followed by lessons from cellular reprogramming of normal cells that may apply to cancer. Lastly, I share my perspective on cellular reprogramming for studying epigenetic alterations that have occurred in tumorigenesis, discuss the current limitations, and propose ways to overcome the obstacles in the reprogramming of cancer.
format Online
Article
Text
id pubmed-7768185
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-77681852020-12-30 Cellular reprogramming to model and study epigenetic alterations in cancer Kim, Jungsun Stem Cell Res Review Although genetic mutations are required for cancer development, reversible non-genetic alterations also play a pivotal role in cancer progression. Failure of well-orchestrated gene regulation by chromatin states and master transcription factors can be one such non-genetic etiology for cancer development. Master transcription factor-mediated cellular reprogramming of human cancer cells allows us to model cancer progression. Here I cover the history and recent advances in reprogramming cancer cells, followed by lessons from cellular reprogramming of normal cells that may apply to cancer. Lastly, I share my perspective on cellular reprogramming for studying epigenetic alterations that have occurred in tumorigenesis, discuss the current limitations, and propose ways to overcome the obstacles in the reprogramming of cancer. Elsevier 2020-12 /pmc/articles/PMC7768185/ /pubmed/33202305 http://dx.doi.org/10.1016/j.scr.2020.102062 Text en © 2020 Published by Elsevier B.V. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kim, Jungsun
Cellular reprogramming to model and study epigenetic alterations in cancer
title Cellular reprogramming to model and study epigenetic alterations in cancer
title_full Cellular reprogramming to model and study epigenetic alterations in cancer
title_fullStr Cellular reprogramming to model and study epigenetic alterations in cancer
title_full_unstemmed Cellular reprogramming to model and study epigenetic alterations in cancer
title_short Cellular reprogramming to model and study epigenetic alterations in cancer
title_sort cellular reprogramming to model and study epigenetic alterations in cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768185/
https://www.ncbi.nlm.nih.gov/pubmed/33202305
http://dx.doi.org/10.1016/j.scr.2020.102062
work_keys_str_mv AT kimjungsun cellularreprogrammingtomodelandstudyepigeneticalterationsincancer